Trials / Sponsors / Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanc Advanced Solid Tumors | Phase 1 | 2025-02-25 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Advanced Solid Tumors, Colorectal Cancer | Phase 1 | 2024-01-25 |
| Terminated | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanc Advanced Solid Tumors, Advanced Hematologic Tumors | Phase 1 | 2024-01-05 |
| Recruiting | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanc Advanced Solid Tumors | Phase 1 | 2023-07-28 |